United States Human Use Rabies Vaccine Market Report 2016

November 2016 | 100 pages | ID: UD6CA4C077BEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Human Use Rabies Vaccine

Revenue, means the sales value of Human Use Rabies Vaccine

This report studies sales (consumption) of Human Use Rabies Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novartis
• Merck
• Sanofi
• GSK
• CYS Pharma
• Sinosource Biopharmaceutical
• Liaoning Chengda
• Dalian Hissen Bio-pharm

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Human Use Rabies Vaccine in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Human Use Rabies Vaccine Market Report 2016

1 HUMAN USE RABIES VACCINE OVERVIEW

1.1 Product Overview and Scope of Human Use Rabies Vaccine
1.2 Classification of Human Use Rabies Vaccine
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Human Use Rabies Vaccine
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Human Use Rabies Vaccine (2011-2021)
  1.4.1 United States Human Use Rabies Vaccine Sales and Growth Rate (2011-2021)
  1.4.2 United States Human Use Rabies Vaccine Revenue and Growth Rate (2011-2021)

2 UNITED STATES HUMAN USE RABIES VACCINE COMPETITION BY MANUFACTURERS

2.1 United States Human Use Rabies Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Human Use Rabies Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Human Use Rabies Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Human Use Rabies Vaccine Market Competitive Situation and Trends
  2.4.1 Human Use Rabies Vaccine Market Concentration Rate
  2.4.2 Human Use Rabies Vaccine Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES HUMAN USE RABIES VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Human Use Rabies Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States Human Use Rabies Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States Human Use Rabies Vaccine Price by Type (2011-2016)
3.4 United States Human Use Rabies Vaccine Sales Growth Rate by Type (2011-2016)

4 UNITED STATES HUMAN USE RABIES VACCINE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Human Use Rabies Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States Human Use Rabies Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES HUMAN USE RABIES VACCINE MANUFACTURERS PROFILES/ANALYSIS

5.1 Novartis
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Human Use Rabies Vaccine Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Novartis Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Merck
  5.2.2 Human Use Rabies Vaccine Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Merck Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sanofi
  5.3.2 Human Use Rabies Vaccine Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sanofi Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 GSK
  5.4.2 Human Use Rabies Vaccine Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 GSK Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 CYS Pharma
  5.5.2 Human Use Rabies Vaccine Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 CYS Pharma Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Sinosource Biopharmaceutical
  5.6.2 Human Use Rabies Vaccine Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Sinosource Biopharmaceutical Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Liaoning Chengda
  5.7.2 Human Use Rabies Vaccine Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Liaoning Chengda Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Dalian Hissen Bio-pharm
  5.8.2 Human Use Rabies Vaccine Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Dalian Hissen Bio-pharm Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview

6 HUMAN USE RABIES VACCINE MANUFACTURING COST ANALYSIS

6.1 Human Use Rabies Vaccine Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Human Use Rabies Vaccine

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Human Use Rabies Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Human Use Rabies Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES HUMAN USE RABIES VACCINE MARKET FORECAST (2016-2021)

10.1 United States Human Use Rabies Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States Human Use Rabies Vaccine Sales Forecast by Type (2016-2021)
10.3 United States Human Use Rabies Vaccine Sales Forecast by Application (2016-2021)
10.4 Human Use Rabies Vaccine Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Human Use Rabies Vaccine
Table Classification of Human Use Rabies Vaccine
Figure United States Sales Market Share of Human Use Rabies Vaccine by Type in 2015
Table Application of Human Use Rabies Vaccine
Figure United States Sales Market Share of Human Use Rabies Vaccine by Application in 2015
Figure United States Human Use Rabies Vaccine Sales and Growth Rate (2011-2021)
Figure United States Human Use Rabies Vaccine Revenue and Growth Rate (2011-2021)
Table United States Human Use Rabies Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Human Use Rabies Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Human Use Rabies Vaccine Sales Share by Manufacturers
Figure 2016 Human Use Rabies Vaccine Sales Share by Manufacturers
Table United States Human Use Rabies Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Human Use Rabies Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Human Use Rabies Vaccine Revenue Share by Manufacturers
Table 2016 United States Human Use Rabies Vaccine Revenue Share by Manufacturers
Table United States Market Human Use Rabies Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Human Use Rabies Vaccine Average Price of Key Manufacturers in 2015
Figure Human Use Rabies Vaccine Market Share of Top 3 Manufacturers
Figure Human Use Rabies Vaccine Market Share of Top 5 Manufacturers
Table United States Human Use Rabies Vaccine Sales by Type (2011-2016)
Table United States Human Use Rabies Vaccine Sales Share by Type (2011-2016)
Figure United States Human Use Rabies Vaccine Sales Market Share by Type in 2015
Table United States Human Use Rabies Vaccine Revenue and Market Share by Type (2011-2016)
Table United States Human Use Rabies Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Human Use Rabies Vaccine by Type (2011-2016)
Table United States Human Use Rabies Vaccine Price by Type (2011-2016)
Figure United States Human Use Rabies Vaccine Sales Growth Rate by Type (2011-2016)
Table United States Human Use Rabies Vaccine Sales by Application (2011-2016)
Table United States Human Use Rabies Vaccine Sales Market Share by Application (2011-2016)
Figure United States Human Use Rabies Vaccine Sales Market Share by Application in 2015
Table United States Human Use Rabies Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States Human Use Rabies Vaccine Sales Growth Rate by Application (2011-2016)
Table Novartis Basic Information List
Table Novartis Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Human Use Rabies Vaccine Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Human Use Rabies Vaccine Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Human Use Rabies Vaccine Sales Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table GSK Human Use Rabies Vaccine Sales Market Share (2011-2016)
Table CYS Pharma Basic Information List
Table CYS Pharma Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table CYS Pharma Human Use Rabies Vaccine Sales Market Share (2011-2016)
Table Sinosource Biopharmaceutical Basic Information List
Table Sinosource Biopharmaceutical Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sinosource Biopharmaceutical Human Use Rabies Vaccine Sales Market Share (2011-2016)
Table Liaoning Chengda Basic Information List
Table Liaoning Chengda Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Liaoning Chengda Human Use Rabies Vaccine Sales Market Share (2011-2016)
Table Dalian Hissen Bio-pharm Basic Information List
Table Dalian Hissen Bio-pharm Human Use Rabies Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dalian Hissen Bio-pharm Human Use Rabies Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Use Rabies Vaccine
Figure Manufacturing Process Analysis of Human Use Rabies Vaccine
Figure Human Use Rabies Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Human Use Rabies Vaccine Major Manufacturers in 2015
Table Major Buyers of Human Use Rabies Vaccine
Table Distributors/Traders List
Figure United States Human Use Rabies Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States Human Use Rabies Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States Human Use Rabies Vaccine Production Forecast by Type (2016-2021)
Table United States Human Use Rabies Vaccine Consumption Forecast by Application (2016-2021)